Cargando…

Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus

Detalles Bibliográficos
Autores principales: Chen, Zhang-Ren, Lv, Qiao-Li, Peng, Hong-Wei, Liu, Xiao-Yi, Hu, Wen-Lei, Hu, Jin-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694522/
https://www.ncbi.nlm.nih.gov/pubmed/36442658
http://dx.doi.org/10.1016/j.jinf.2022.11.018
_version_ 1784837821168615424
author Chen, Zhang-Ren
Lv, Qiao-Li
Peng, Hong-Wei
Liu, Xiao-Yi
Hu, Wen-Lei
Hu, Jin-Fang
author_facet Chen, Zhang-Ren
Lv, Qiao-Li
Peng, Hong-Wei
Liu, Xiao-Yi
Hu, Wen-Lei
Hu, Jin-Fang
author_sort Chen, Zhang-Ren
collection PubMed
description
format Online
Article
Text
id pubmed-9694522
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-96945222022-11-30 Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus Chen, Zhang-Ren Lv, Qiao-Li Peng, Hong-Wei Liu, Xiao-Yi Hu, Wen-Lei Hu, Jin-Fang J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-11-25 /pmc/articles/PMC9694522/ /pubmed/36442658 http://dx.doi.org/10.1016/j.jinf.2022.11.018 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Elsevier has created a Monkeypox Information Center (https://www.elsevier.com/connect/monkeypox-information-center) in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active.
spellingShingle Letter to the Editor
Chen, Zhang-Ren
Lv, Qiao-Li
Peng, Hong-Wei
Liu, Xiao-Yi
Hu, Wen-Lei
Hu, Jin-Fang
Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
title Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
title_full Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
title_fullStr Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
title_full_unstemmed Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
title_short Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
title_sort drug screening against f13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694522/
https://www.ncbi.nlm.nih.gov/pubmed/36442658
http://dx.doi.org/10.1016/j.jinf.2022.11.018
work_keys_str_mv AT chenzhangren drugscreeningagainstf13proteinthetargetoftecovirimataspotentialtherapiesformonkeypoxvirus
AT lvqiaoli drugscreeningagainstf13proteinthetargetoftecovirimataspotentialtherapiesformonkeypoxvirus
AT penghongwei drugscreeningagainstf13proteinthetargetoftecovirimataspotentialtherapiesformonkeypoxvirus
AT liuxiaoyi drugscreeningagainstf13proteinthetargetoftecovirimataspotentialtherapiesformonkeypoxvirus
AT huwenlei drugscreeningagainstf13proteinthetargetoftecovirimataspotentialtherapiesformonkeypoxvirus
AT hujinfang drugscreeningagainstf13proteinthetargetoftecovirimataspotentialtherapiesformonkeypoxvirus